Cargando…

Serum levetiracetam concentrations after transdermal levetiracetam administration, 3 times daily, to healthy cats

BACKGROUND: Repeated oral administration of antiepileptic drugs can be challenging for cat owners, resulting in reduced compliance, poor seizure control, and reduced quality of life for cats. Levetiracetam (LEV) has several properties that make it an appealing drug for transdermal application. OBJEC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Casey, Barnes Heller, Heidi L., Reif, Nicole, Van Hesteren, Matthew, Reinhart, Jennifer M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430925/ https://www.ncbi.nlm.nih.gov/pubmed/30663797 http://dx.doi.org/10.1111/jvim.15412

Ejemplares similares

Serum levetiracetam concentrations and adverse events after multiple dose extended release levetiracetam administration to healthy cats
por: Barnes Heller, Heidi, et al.
Publicado: (2018)

Pharmacokinetics of Single Oral Dose Extended‐Release Levetiracetam in Healthy Cats
por: Barnard, L., et al.
Publicado: (2017)

Disposition of Extended Release Levetiracetam in Normal Healthy Dogs After Single Oral Dosing
por: Beasley, M.J., et al.
Publicado: (2015)

Levetiracetam‐responsive paroxysmal exertional dyskinesia in a Welsh Terrier
por: Green, Sherril, et al.
Publicado: (2021)

Open‐label clinical trial of rectally administered levetiracetam as supplemental treatment in dogs with cluster seizures
por: Cagnotti, Giulia, et al.
Publicado: (2019)

Population pharmacokinetics of extended‐release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamide
por: Muñana, Karen R., et al.
Publicado: (2018)

A pilot study of transdermal gabapentin in cats
por: Slovak, Jennifer E., et al.
Publicado: (2021)

Posaconazole Pharmacokinetics in Healthy Cats after Oral and Intravenous Administration
por: Mawby, D.I., et al.
Publicado: (2016)

Pharmacokinetics of isavuconazole in healthy cats after oral and intravenous administration
por: Woerde, Dennis J., et al.
Publicado: (2022)

Levetiracetam Rectal Administration in Healthy Dogs
por: Peters, R.K., et al.
Publicado: (2014)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Plasma and urinary metanephrine and normetanephrine concentrations using liquid chromatography with tandem mass spectrometry in healthy cats and in a cat with pheochromocytoma
por: Prego, Maria Teresa, et al.
Publicado: (2023)

Glucose concentrations after insulin‐induced hypoglycemia and glycemic variability in healthy and diabetic cats
por: Zini, Eric, et al.
Publicado: (2018)

Serum insulin‐like growth factor‐1 concentrations in healthy cats before and after weight gain and weight loss
por: Zini, Eric, et al.
Publicado: (2021)

Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease
por: Williams, T.L., et al.
Publicado: (2016)

Evaluation of urine concentrations of amoxicillin and clavulanate in cats
por: KuKanich, Kate, et al.
Publicado: (2020)

Long‐term incidence and risk of noncardiovascular and all‐cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy
por: Fox, Philip R., et al.
Publicado: (2019)

Heart murmurs in apparently healthy cats caused by iatrogenic dynamic right ventricular outflow tract obstruction
por: Ferasin, Luca, et al.
Publicado: (2020)

Serum thyroxine and thyrotropin concentrations decrease with severity of nonthyroidal illness in cats and predict 30‐day survival outcome
por: Peterson, Mark E., et al.
Publicado: (2020)

Comparison of 2 assays for measuring serum total thyroxine concentration in dogs and cats
por: Wolff, Ewan D. S., et al.
Publicado: (2020)

Microbiome analysis of bile from apparently healthy cats and cats with suspected hepatobiliary disease
por: Slead, Tanner S., et al.
Publicado: (2023)

Whole‐Blood Taurine Concentrations in Cats With Intestinal Disease
por: Kathrani, A., et al.
Publicado: (2017)

Stability and profiling of urinary microRNAs in healthy cats and cats with pyelonephritis or other urological conditions
por: Jessen, Lisbeth R., et al.
Publicado: (2019)

Pharmacokinetics of mycophenolic acid and its effect on CD4(+) and CD8(+) T cells after oral administration of mycophenolate mofetil to healthy cats
por: Slovak, Jennifer E., et al.
Publicado: (2019)

Evaluation of Serum Thyroid‐Stimulating Hormone Concentration as a Diagnostic Test for Hyperthyroidism in Cats
por: Peterson, M.E., et al.
Publicado: (2015)

Evaluation of Gastric pH and Serum Gastrin Concentrations in Cats with Chronic Kidney Disease
por: Tolbert, M.K., et al.
Publicado: (2017)

Serum Beta Hydroxybutyrate Concentrations in Cats with Chronic Kidney Disease, Hyperthyroidism, or Hepatic Lipidosis
por: Gorman, L., et al.
Publicado: (2016)

Serum Cobalamin and Methylmalonic Acid Concentrations in Hyperthyroid Cats Before and After Radioiodine Treatment
por: Geesaman, B.M., et al.
Publicado: (2016)

Psychometric Validation of a General Health Quality of Life Tool for Cats Used to Compare Healthy Cats and Cats with Chronic Kidney Disease
por: Bijsmans, E.S., et al.
Publicado: (2016)

Blood Pressure Measurements in 780 Apparently Healthy Cats
por: Payne, J.R., et al.
Publicado: (2016)

Biological variation of major gut‐derived uremic toxins in the serum of healthy adult cats
por: Summers, Stacie, et al.
Publicado: (2021)

Risk factors associated with progressive increases in serum creatinine concentrations in cats with cancer receiving doxorubicin
por: Kopecny, Lucy, et al.
Publicado: (2020)

International collaborative study to assess cardiovascular risk and evaluate long‐term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study
por: Fox, Philip R., et al.
Publicado: (2018)

Computed tomographic appearance of abdominal lymph nodes in healthy cats
por: Perlini, Michael, et al.
Publicado: (2018)

Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats
por: Roche‐Catholy, Marine, et al.
Publicado: (2022)

Antigen Concentrations as an Indicator of Clinical Remission and Disease Relapse in Cats with Histoplasmosis
por: Hanzlicek, A.S., et al.
Publicado: (2016)

Fibroblast growth factor 23 and symmetric dimethylarginine concentrations in geriatric cats
por: Sargent, Hannah J., et al.
Publicado: (2019)

Evaluation of Serum Symmetric Dimethylarginine Concentration as a Marker for Masked Chronic Kidney Disease in Cats With Hyperthyroidism
por: Peterson, M.E., et al.
Publicado: (2018)

The fecal microbiome and serum concentrations of indoxyl sulfate and p‐cresol sulfate in cats with chronic kidney disease
por: Summers, Stacie C., et al.
Publicado: (2018)

Received dose variability after administration of I‐131 for treatment of hyperthyroidism in cats
por: Busser, Suzanne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_be5hp28tkv0qqlcb1hl11e483f